Drugs / SYN060
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03254810 | Sep 2017 → Jul 2018 | rheumatoid arthritis | Synermore Biologics Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SYN060 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03254810 ↗ |
| Route | Subcutaneous | “a single subcutaneous 0.57 mg/kg dose of SYN060” NCT03254810 ↗ |